Oncology & Cancer

Potential upgrades on in vitro toxicological cell-based models

Over the last 100 years, knowledge regarding drug toxicity has increased significantly, especially since the thalidomide tragedy of the mid-20th century. This tragedy marked the beginning of rigorous drug approval and monitoring ...

Medical research

New treatment for muscular dystrophy wins US regulatory approval

Research led by Professor Steve Wilton and Professor Sue Fletcher and licensed to Sarepta Therapeutics has delivered a second treatment for Duchenne muscular dystrophy, with the drug gaining accelerated approval by the U.S. ...

Health

Social bots tweet dodgy claims about pot, diluting solid science

A USC analysis of tens of thousands of cannabis-related posts on Twitter found that social bots regularly perpetuated bogus health claims on the platform, illustrating how false statements may drown out solid science on social ...

Oncology & Cancer

First-in-human trial for new lung cancer immunotherapy

Cancer Research UK and Vaccitech Oncology Limited (VOLT), today (Wednesday) announce a new partnership to bring a novel immunotherapeutic vaccine strategy to patients with lung cancer.

Oncology & Cancer

Ultrasound blasts potent glioblastoma drug into brain tumor

One of most potent drugs for treatment of glioblastoma, the most deadly type of brain tumor, can't be used in patients because of two problems. First, it can't reach its target because it's blocked by the blood-brain barrier, ...

page 33 from 40